Other researchers found a decreased expression of BCL-2 in atypical hyperplasia and endometrial adenocarcinoma [1, 3], highlighting the need for further research to understand the specific mechanisms and roles of BCL-2 in oncogenesis and potential therapeutic interventions [2, 7]. Here, BCL2 is linked to endometrium adenocarcinoma.